Brevan Howard Capital Management LP Immunity Bio, Inc. Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 345,944 shares of IBRX stock, worth $923,670. This represents 0.01% of its overall portfolio holdings.
Number of Shares
345,944
Previous 99,757
246.79%
Holding current value
$923,670
Previous $255,000
308.24%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IBRX
# of Institutions
238Shares Held
79.7MCall Options Held
1.08MPut Options Held
2.73M-
Vanguard Group Inc Valley Forge, PA20.3MShares$54.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$30.5 Million0.0% of portfolio
-
State Street Corp Boston, MA7.58MShares$20.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.29MShares$11.5 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.45MShares$9.2 Million0.07% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.07B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...